Joined-Up EU Approach Is Key To Continuing COVID-19 Fight

Multi-Stakeholder Approach Must Be Maintained, Medicines For Europe Insists

09 Jul 2020

At a Medicines for Europe webinar on learning lessons from the COVID-19 pandemic, a clear consensus emerged that a continued co-ordination between industry, regulators and the European Commission was key to both effectively address the current crisis and ensure a greater level of preparedness for similar challenges in future.

Continued high-level co-ordination between the off-patent industry, regulators and the European Commission is key to ensure that the region continues to effectively address the coronavirus pandemic, as well as preparing itself for future similar crises, according to participants at a roundtable hosted by off-patent industry association Medicines for Europe.

Speaking today as part of a panel at a webinar on “lessons learned from COVID-19” Teva’s Christoph Stoller, president of...